Pharmacy data in the VA health care system

Medical Care Research and Review

Volumn 60, Issue 3 SUPPL., 2003, Pages

  Smith, Mark W ^a,b   Joseph, George J ^c  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY   (United States)

^c HINES VA HOSPITAL   (United States)

Author keywords

Cost; Economics; Medicine; Mirco costing; Pharmacy

Indexed keywords

GENERIC DRUG; INSULIN LISPRO; METOPROLOL; OLANZAPINE; SILDENAFIL; CORTICOSTEROID; GEMFIBROZIL; METOPROLOL TARTRATE;

AGE DISTRIBUTION; DATA BASE; DISABILITY; DRUG COST; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; INFORMATION; OUTPATIENT; PHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST EFFECTIVENESS ANALYSIS; DATA EXTRACTION; DEMOGRAPHY; ELECTRONIC MEDICAL RECORD SYSTEM; HEALTH CARE ACCESS; HOSPITAL PATIENT; MEDICAL CARE; MEDICAL INFORMATION SYSTEM; MEDICAL RESEARCH; OUTPATIENT CARE; PHARMACIST; PHYSICIAN; QUALITY CONTROL; VETERANS HEALTH;

EID: 0042242561     PISSN: 10775587     EISSN: None     Source Type: Journal    
DOI: 10.1177/1077558703256726     Document Type: Review

References (32)

1. Barnett, P.G., S. Chen, W. E. Boden, B. Chow, N. R. Every, P. W. Lavori, and M. A. Hlatky. 2002. Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction. Circulation 105: 680-84.
2. Barnett, P. G., and J. H. Rodgers. 1999. Use of the Decision Support System for VA cost-effectiveness research. Medical Care 37 (4 Suppl. VA): AS63-70.
3. Cunningham, F., M. Sales, and M. Valentino. 2001. The Pharmacy Benefits Management (PBM) database: A primary resource for nation-wide VA medication data. VIReC Insights 2.
4. Fishman, P. A., M. J. Goodman, M. C. Hornbrook, R. T. Meenan, D. J. Bachman, and M. C. O'Keefe Rosetti. 2003. Risk adjustment using automated ambulatory pharmacy data: The RxRisk model. Medical Care 41 (1): 84-99.
5. -, and D. K. Shay. 1999. Development and estimation of a pediatric chronic disease score using automated pharmacy data. Medical Care 37 (9): 874-83.
6. Fortney, J., K. Rost, M. Zhang, and J. Pyne. 2001. The relationship between quality and outcomes in routine depression care. Psychiatric Services 52 (1): 56-62.
7. Gilmer, T., R. Kronick, P. Fishman, and T. G. Ganiats. 2001. The Medicaid Rx model: Pharmacy-based risk adjustment for public programs. Medical Care 39 (11): 1188-202.
8. Hoffman, L., J. Enders, J. Luo, R. Segal, J. Pippins, and C. Kimberlin. 2003. Impact of an antidepressant management program on medication adherence. American Journal of Managed Care 9 (1): 70-80.
9. Hynes, D. M., G. Joseph, and C. Pfeil. 2002. Veterans Health Information Systems and Technology Architecture (VISTA) as a research tool. VIReC Insights 3 (1): 1-7.
10. Keiser, P., M. B. Kvanli, D. Turner, J. Reisch, J. W. Smith, N. Nassar, C. Gregg, and D. Skiest. 1999. Protease inhibitor-based therapy is associated with decreased HIV-related health care costs in men treated at a Veterans Administration Hospital. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 20:28-33.
11. Lamers, L. M. 1999. Pharmacy costs groups: A risk-adjuster for capitation payments based on the use of prescribed drugs. Medical Care 37 (8): 824-30.
12. Leslie, D. L., and R. A. Rosenheck. 2001a. The effect of institutional fiscal stress on the use of atypical antipsychotic medications in the treatment of schizophrenia. Journal of Nervous and Mental Disease 189 (6): 377-83.
13. -. 2001b. Use of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system: Individual and facility predictors. Medical Care 39 (9): 923-33.
14. Maciejewski, M. L., M. K. Chapko, A. N. Hedeen, and J. C. Fortney. 2002. VA community-based outpatient clinics: Cost performance measures. Medical Care 40 (7): 587-95.
15. Mark, T. L., R. Dirani, E. Slade, and P. A. Russo. 2002. Access to new medications to treat schizophrenia. Journal of Behavioral Health Services Research 29 (1): 15-29.
16. Melfi, C. A., A. J. Chawla, T. W. Croghan, M. P. Hanna, S. Kennedy, and K. Sredl. 1998. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Archives of General Psychiatry 55 (12): 1128-32.
17. Murphy, P. A., D. C. Cowper, G. Seppala, K. T. Stroupe, and D. M. Hynes. 2002. Veterans Health Administration inpatient and outpatient care data: An overview. Effective Clinical Practice 5 (3 Suppl): E4.
18. Newton, K. M., A. Z. LaCroix, D. S. Buist, L. A. Anderson, and K. Delaney. 2001. What factors account for hormone replacement therapy prescribing frequency? Maturitas 39 (1):1-10..
19. Nyman, J. A., M. S. Martinson, D. Nelson, S. Nugent, D. Collins, J. Wittes, C. L. Fye, T. J. Wilt, S. J. Robins, and H. Bloomfield Rubins. 2002. Cost-effectiveness of gemfibrozil for coronary heart disease patients with low levels of high-density lipoprotein cholesterol: The Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial. Archives of Internal Medicine 162 (2): 177-82.
20. Ogden, J. E., A. Muniz, A. A. Patterson, D. J. Ramirez, and K. W. Kizer. 1997. Pharmaceutical services in the Department of Veterans Affairs. American Journal of Health-System Pharmacy 54 (7): 761-5.
21. Parks Thomas, C., G. Ritter, and S. S. Wallack. 2001. Growth in prescription drug spending among insured elders. Health Affairs 20 (5): 265-77.
22. Pillans, P. I., P. A. Kubler, J. M. Radford, and V. Overland. 2000. Concordance between use of proton pump inhibitors and prescribing guidelines. Medical Journal of Australia 172 (1):16-18.
23. Schoen, M. D., R. J. DiDomenico, S. E. Connor, J. E. Dischler, and J. L. Bauman. 2001. Impact of the cost of prescription drugs on clinical outcomes in indigent patients with heart disease. Pharmacotherapy 21 (12): 1455-63.
24. Sernyak, M. J., D. L. Leslie, R. D. Alarcon, M. F. Losonczy, and R. A. Rosenheck. 2002. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. American Journal of Psychiatry 159 (4): 561-6.
25. Shen, Y., A. Hendricks, S. Zhang, and L. E. Kazis. 2003. VHA enrollees' health care coverage and use of care. Medical Care Research and Review (in press).
26. Smith, J. L., K. M. Rost, P. A. Nutting, and C. E. Elliott. 2001. Resolving disparities in antidepressant treatment and quality-of-life outcomes between uninsured and insured primary care patients with depression. Medical Care 39 (9): 910-22.
27. U.S. Department of Veterans Affairs. 2002. Medication copayment [pamphlet]. Washington, DC: U.S. Department of Veterans Affairs.
28. U.S. General Accounting Office. 2000. Prescription drugs: Expanding access to federal prices could cause other price changes. Washington, DC: U.S. Government Accounting Office.
29. Valenstein, M., L. A. Copeland, F. C. Blow, J. F. McCarthy, J. E. Zeber, L. Gillon, C. R. Bingham, and T. Stavenger. 2002. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care 40 (8): 630-9.
30. Veterans Health Administration. 2003. 2003-2004 VISTA Monograph. Washington, DC: U.S. Department of Veterans Affairs, Veterans Health Administration. Available at http://www.va.gov/vista_monograph/docs/12_02_03-04Monograph_ FinalPrinted.pdf (accessed May 2, 2003).
31. Yu, W., and P. G. Barnett. 2002a. Research guide to Decision Support System national cost extracts: 1998-2000. Menlo Park, CA: VA Health Economics Resource Center.
32. -. 2002b. Reconciliation of DSS encounter-level National Data Extracts with the VA National Patient Care Database, FY2001. HERC Technical Report no. 3. Menlo Park, CA: VA Health Economics Resource Center.